Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

13.00HKD
6:26am BST
Change (% chg)

HK$0.56 (+4.50%)
Prev Close
HK$12.44
Open
HK$12.70
Day's High
HK$13.18
Day's Low
HK$12.60
Volume
31,469,280
Avg. Vol
30,963,860
52-wk High
HK$21.20
52-wk Low
HK$9.90

Summary

Name Age Since Current Position

Dongchen Cai

65 2010 Executive Chairman of the Board, Chief Executive Officer

Cuilong Zhang

50 2019 Executive Vice Chairman of the Board, Rotating Chief Executive Officer

Kin Man Chak

53 2005 Executive Director

Chunlei Li

42 2017 Executive Director

Hua Lu

47 2015 Executive Director

Weidong Pan

49 2019 Executive Director

Huaiyu Wang

55 2010 Executive Director

Qingxi Wang

53 2018 Executive Director

Zhenguo Wang

49 2019 Executive Director

Ka Sze Lee

58 2004 Company Secretary, Non-Executive Director

Siu Keung Chan

61 2004 Independent Non-Executive Director

Chuan Chen

55 2016 Independent Non-Executive Director

Yuk Lam Lo

70 2014 Independent Non-Executive Director

Bo Wang

59 2012 Independent Non-Executive Director

Jinming Yu

61 2014 Independent Non-Executive Director

Biographies

Name Description

Dongchen Cai

Mr. Cai Dongchen is Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”). Mr. Cai is also a director of True Ally Holdings Limited and Massive Giant Group Limited, both are substantial shareholders of the Company within the meaning of Part XV of the SFO.

Cuilong Zhang

Mr. Zhang Cuilong is Executive Vice Chairman of the Board, Rotating Chief Executive Officer of the Company. Mr. Zhang is also a director of certain subsidiaries of the Group. Mr. Zhang holds a bachelor’s degree in pharmacology from Hebei Medical College (now known as Hebei Medical University) and has extensive technical, marketing and management experience in the pharmaceutical industry

Kin Man Chak

Mr. Chak Kin Man is Executive Director of the Company. Mr. Chak is also a director of certain subsidiaries of the Group. Mr. Chak is also a director of certain subsidiaries of the Group. Mr. Chak is a certified public accountant of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. Mr. Chak holds a bachelor of social sciences degree from The University of Hong Kong and has extensive experience in finance, accounting and investor relations. Mr. Chak is a director of Common Success International Limited, a substantial shareholder of the Company within the meaning of Part XV of the SFO.

Chunlei Li

Mr. Li Chunlei is Executive Director of the Company. Dr. Li is currently the Chief Scientist of the Group in charge of research and development. Dr. Li is also the general manager of a subsidiary of the Company, deputy director of the Novel Pharmaceutical Preparations and Excipients State Key Laboratory and director of the Hebei Pharmaceutical Engineering Technology Centre. Dr. Li holds a bachelor’s degree in engineering (biological pharmaceutics) from Jilin University and Shenyang Pharmaceutical University, a master’s degree in science (microbial and biochemical pharmaceutics) from Jilin University and a doctorate in science (pharmaceutical science) from Shenyang Pharmaceutical University.

Hua Lu

Mr. Lu Hua is Executive Director of the Company. Mr. Lu is also a director of certain subsidiaries of the Group. Dr. Lu is also a director of certain subsidiaries of the Group. Dr. Lu holds a bachelor’s degree in science (chemistry) from Hebei Normal University, a master’s degree in engineering (pharmaceutical manufacturing) from Beijing University of Chemical Technology, an EMBA degree from Tsinghua University and a doctorate in engineering (pharmaceutical manufacturing) from Tianjin University. Dr. Lu has extensive experience in pharmaceutical engineering, production management and technical research.

Weidong Pan

Mr. Weidong Pan is an Executive Director of the Company. Mr. Pan is also a director of certain subsidiaries of the Group. Mr. Pan holds an EMBA degree from Tsinghua University and has extensive finance, accounting and investment experience in the pharmaceutical industry. Mr. Pan is a director of Common Success International Limited, a substantial shareholder of the Company within the meaning of Part XV of the SFO.

Huaiyu Wang

Mr. Wang Huaiyu is Executive Director of the Company. Mr. Wang is also a director of certain subsidiaries of the Group. Mr. Wang holds a bachelor’s degree in microbiology and biochemistry from Hebei University and has extensive technical and management experience in the pharmaceutical industry

Qingxi Wang

Dr. Wang Qingxi serves as Executive Director of the Company. Dr. Wang is also a director of certain subsidiaries of the Group. Prior to joining the Group, Dr. Wang worked at Merck & Co., Inc. in the U.S. for 20 years where he held senior positions including director of pharmaceutical R&D and director of business development and operation. Dr. Wang holds a bachelor’s degree in science (chemistry) and a master’s degree in science (chemistry) from Nankai University in China, a master’s degree in science (polymer science) and a doctorate in chemistry from University of Connecticut in the U.S. and a MBA degree from Temple University in the U.S..

Zhenguo Wang

Mr. Wang Zhenguo is Executive Director of the Company. Mr. Wang is also a director of certain subsidiaries of the Group. Mr. Wang holds a bachelor’s degree in chemistry from Nankai University and has extensive technical and management experience in the pharmaceutical industry.

Ka Sze Lee

Mr. Lee Ka Sze is Company Secretary, Non-Executive Director of the Company. He was appointed as a non-executive director in 1996, re-designated as an independent nonexecutive director in 1998 and further re-designated as a non-executive director in 2004. Mr. Lee is also a member of the Audit Committee and Remuneration Committee and the Company Secretary of the Company. Mr. Lee holds a bachelor of laws degree from The University of Hong Kong. Mr. Lee is a practising solicitor and a partner of Woo, Kwan, Lee & Lo. Mr. Lee is also a non-executive director of Hopewell Holdings Limited, Yugang International Limited, Safety Godown Company Limited and Termbray Industries International (Holdings) Limited and an independent non-executive director of KWG Property Holding Limited, Esprit Holdings Limited and China Pacific Insurance (Group) Co., Ltd.. All of the above companies are listed on the Stock Exchange of Hong Kong Limited. Mr. Lee is currently a member of the SFC (HKEC Listing) Committee and convenor cum member of the Financial Reporting Review Panel of the Financial Reporting Council.

Siu Keung Chan

Mr. Chan Siu Keung is Independent Non-Executive Director of the Company. Mr. Chan is also the chairman of the Audit Committee and Remuneration Committee and a member of the Nomination Committee of the Company. Mr. Chan is a qualified accountant and a member of the Institute of Chartered Accountants of Ontario. Mr. Chan holds a master of business administration degree from York University, Ontario, Canada and has extensive experience in finance and investment.

Chuan Chen

Mr. Chen Chuan is Independent Non-Executive Director of the Company. Mr. Chen holds a bachelor’s degree in Medicine from Norman Bethune University of Medical Science and a Master’s degree in Science from Albert Einstein College of Medicine at Yeshiva University. Mr. Chen is also a director of Beijing Dong Fang Ming Kang Medical Equipment Co., Ltd. (quoted on the National Equities Exchange and Quotations System).

Yuk Lam Lo

Prof. Lo Yuk Lam is Independent Non-Executive Director of the Company since 2014. He is also a member of the Nomination Committee of the Company. Prof. Lo is currently the President of Santai Biotechnology Research Institute, Vice-Chairman of Santai Eco Fishery Limited, Chairman of Lo & Associates Limited, Senior Director of Questmark Asia Limited and Senior Advisor of Questmark Capital Management Sdn. Bhd.. Prof. Lo is also involved in public services, currently serving as Chairman of the Advisory Council on Food and Environmental Hygiene of the Food and Health Bureau of the HKSAR, a member of the Advisory Committee of the Vocational Training Council, a general committee member of The Chinese Manufacturers’ Association of Hong Kong (“CMA”), Chairman of the Innovation and Technology Committee of the CMA and a consultant of the Chinese Centre for Disease Control and Prevention. Prof. Lo is also an Adjunct Professor of The Chinese University of Hong Kong, a Fellow of The Hong Kong University of Science and Technology and an Honorary Professor of several universities in China. Prof. Lo holds a bachelor’s degree in science from the University of Waterloo and an honorary doctorate of philosophy science from York University in the U.S.. Prof. Lo is also an independent director of Sinovac Biotech Limited (listed on NASDAQ) and an independent non-executive director of Luye Pharma Group Ltd. (listed on The Stock Exchange of Hong Kong Limited).

Bo Wang

Mr. Wang Bo is Independent Non-Executive Director of CSPC Pharmaceutical Group Limited. He is also a member of the Audit Committee and Remuneration Committee of the Company. Mr. Wang is currently the CEO of Beijing CHNMED Pharmaceutical Technology Development Co., Ltd and managing director of Beijing CHNMED Pharmaceutical Consulting Co., Ltd.. Mr. Wang graduated from Beijing Institute of Iron and Steel and has extensive experience in pharmaceutical policy research and consulting. Mr. Wang is currently the distinguished researcher of the Research Center of National Drug Policy & Ecosystem. Mr. Wang is also an independent director of Henan Taloph Pharmaceutical Stock Co., Ltd. (listed on Shanghai Stock Exchange) and Jiuzhitang Co., Ltd. (listed on Shenzhen Stock Exchange).

Jinming Yu

Mr. Yu Jinming is Independent Non-Executive Director of the Company. Dr. Yu is an Academician of Chinese Academy of Engineering, and is currently the Honorary President of Shandong Academy of Medical Sciences and the President of Shandong Cancer Hospital. Dr. Yu holds a bachelor’s degree in medicine from Changwei Medical College and a doctorate in radiology from Shandong University.

Basic Compensation

Name Fiscal Year Total

Dongchen Cai

13,805,000

Cuilong Zhang

4,326,000

Kin Man Chak

5,269,000

Chunlei Li

4,783,000

Hua Lu

4,205,000

Weidong Pan

4,387,000

Huaiyu Wang

4,205,000

Qingxi Wang

1,692,000

Zhenguo Wang

4,438,000

Ka Sze Lee

350,000

Siu Keung Chan

250,000

Chuan Chen

100,000

Yuk Lam Lo

120,000

Bo Wang

100,000

Jinming Yu

80,000
As Of  31 Dec 2018